Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease.
Saved in:
| Title: | Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease. |
|---|---|
| Authors: | Mutavhatsindi H; Department of Science and Innovation - National Research Foundation (DSI-NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., van der Spuy GD; Department of Science and Innovation - National Research Foundation (DSI-NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Malherbe ST; Department of Science and Innovation - National Research Foundation (DSI-NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Sutherland JS; TB Research Group, Medical Research Council Gambia at London School of Hygiene and Tropical Medicine (LSHTM), Banjul, Gambia., Geluk A; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, Netherlands., Mayanja-Kizza H; Department of Internal Medicine and Immunology, School of Medicine, Makerere University, Kampala, Uganda., Crampin AC; Karonga Prevention Study, London School of Hygiene and Tropical Medicine, Karonga, Malawi., Kassa D; Infectious and Non-Infectious Diseases Research Directorate, Ethiopian Health and Nutrition Research Institute, Addis Ababa, Ethiopia., Howe R; Department of Immunology, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Mihret A; Department of Immunology, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Sheehama JA; Department of Biochemistry & Microbiology, School of Medicine, University of Namibia, Windhoek, Namibia., Nepolo E; Department of Biochemistry & Microbiology, School of Medicine, University of Namibia, Windhoek, Namibia., Günther G; Department of Biochemistry & Microbiology, School of Medicine, University of Namibia, Windhoek, Namibia., Dockrell HM; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Corstjens PLAM; Department of Molecular Cell Biology, Leiden University Medical Centre, Leiden, Netherlands., Stanley K; Department of Science and Innovation - National Research Foundation (DSI-NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Walzl G; Department of Science and Innovation - National Research Foundation (DSI-NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Chegou NN; Department of Science and Innovation - National Research Foundation (DSI-NRF) Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. |
| Corporate Authors: | AE-TBC ScreenTB Consortia |
| Source: | Frontiers in immunology [Front Immunol] 2021 Feb 26; Vol. 12, pp. 607827. Date of Electronic Publication: 2021 Feb 26 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2021.607827 |
